Federal Policy
5Federal Policy·7:30 AM MT
The Trump Administration finalized a rule that restricts medical frailty exemptions from the Medicaid work requirement enacted in the 2025 reconciliation law. The rule narrows exemptions for blindness, disability, substance use disorder, disabling mental disorders, and physical, intellectual, or developmental disabilities that impair ability to perform daily activities. The work requirement takes Medicaid coverage from enrollees who do not meet the requirement and do not qualify for an exemption. The rule is now in effect following finalization.
Why it matters for managed careMedicaid MCOs will face increased disenrollment of members who cannot meet work requirements or qualify for narrowed medical exemptions, affecting revenue, medical loss ratios, and administrative burden related to exemption verification and member appeals.
Federal Policy·1:30 PM MT
The Trump administration notified state Medicaid directors last week that it will implement more stringent financial oversight of Section 1115 demonstration waivers. The changes affect the waiver process that states use to design and operate Medicaid pilot programs and demonstrations. CMS sent letters to state Medicaid directors announcing the new oversight requirements. The policy shift represents increased federal scrutiny of state demonstration projects, which often include managed care delivery system reforms and coverage expansions.
Why it matters for managed careStricter waiver oversight may limit states' flexibility to modify MCO contracts, carved-in benefits, and delivery system designs under existing demonstrations, potentially requiring new federal approvals for operational changes.
Federal Policy·1:31 PM MT
Senate Democrats Ron Wyden and Maggie Hassan have launched an investigation into Health Secretary Robert F. Kennedy Jr.'s restructuring of the Advisory Committee on Immunization Practices (ACIP), the federal panel that issues vaccine recommendations. The senators are demanding communications and records showing who determined the legal and public health consequences of remaking the advisory committee. ACIP recommendations typically inform Medicaid and CHIP coverage decisions for vaccines under the Vaccines for Children program and mandatory coverage requirements for pediatric vaccines. The investigation seeks transparency around the decision-making process that led to changes in the federal vaccine policy infrastructure.
Why it matters for managed careChanges to ACIP composition or process could affect vaccine coverage mandates for Medicaid and CHIP enrollees, particularly the Vaccines for Children program that provides federally funded vaccines to Medicaid-eligible children.
Federal Policy·7:32 AM MT
The CDC reported nitazene-involved overdose deaths increased from 27 in 2020 to 409 in 2024, marking a 1,415% rise in confirmed fatalities from these super-potent synthetic opioids. Nitazenes are spreading across the U.S. drug supply, often mixed with or sold as other substances. The sharp escalation indicates an emerging public health threat requiring enhanced overdose response capacity. This trend follows patterns seen with fentanyl's emergence in the illicit drug market over the past decade.
Why it matters for managed careMedicaid managed care organizations may face increased emergency department utilization, overdose response costs, and need for expanded medication-assisted treatment capacity as nitazenes spread through their service areas.
Federal Policy·7:32 AM MT
CMS issued a request for information on pharmacy benefit manager compensation structures and business practices to inform implementation of new legislative requirements. The RFI focuses on two mandates taking effect in 2028: restrictions on remuneration PBMs and affiliates may receive for services related to Part D drug utilization, and new data reporting requirements. CMS is seeking technical input on PBM service arrangements, affiliate relationships, and compensation models. Comments will shape how CMS defines permissible PBM compensation and structures data collection requirements for Medicare Part D plans.
Why it matters for managed careMedicaid managed care organizations with integrated Part D plans or pharmacy benefit arrangements structured similarly to Medicare will need to monitor the resulting compensation restrictions and reporting requirements, as state Medicaid programs increasingly scrutinize PBM arrangements and may adopt parallel transparency and compensation limitations.
State Policy
3State Policy·NC·7:30 AM MT
North Carolina lawmakers are pursuing tighter regulatory requirements for applied behavioral analysis (ABA) therapy providers following combined state and federal Medicaid spending of over $505 million in 2025. The proposed rules aim to reduce fraud and abuse in the rapidly growing autism treatment sector. The legislation would impose additional credentialing, supervision, and documentation standards on ABA providers participating in Medicaid. This follows nationwide scrutiny of ABA billing practices and improper payments in state Medicaid programs.
Why it matters for managed careManaged care organizations contracting with ABA providers face potential network disruption, increased credentialing requirements, and heightened claims review obligations if North Carolina implements stricter provider standards.
State Policy·MS·1:30 PM MT
The Mississippi Division of Medicaid filed a motion in bankruptcy court Wednesday requesting permission to withhold a scheduled $2.4 million payment to Greenwood Leflore Hospital. The hospital, currently operating under Chapter 11 bankruptcy protection, has warned the payment withholding could force immediate closure. The dispute arises as the state Medicaid program exercises its authority to recoup or withhold payments from providers in financial distress. If approved, the action would remove critical operating revenue from a hospital serving a predominantly Medicaid-eligible population in the Mississippi Delta.
Why it matters for managed careManaged care organizations with Greenwood Leflore Hospital in their provider networks face potential network adequacy gaps and member disruption if the facility closes due to the payment withholding.
State Policy·CA·1:31 PM MT
The California Department of Managed Health Care identified 70 Knox-Keene Act violations across three investigation rounds involving commercial health plans' delivery of behavioral health services for mental health and substance use disorder treatment. The violations indicate systemic failures in timely access to care. While these investigations targeted commercial plans regulated under Knox-Keene, the findings may signal enforcement priorities that could extend to Medi-Cal managed care plans, which are also subject to DMHC oversight and similar network adequacy standards for behavioral health.
Why it matters for managed careDMHC's aggressive enforcement posture on behavioral health access in commercial plans suggests heightened scrutiny for Medi-Cal MCOs, which face similar network adequacy requirements and may be subject to comparable audit protocols.
Industry
2Industry·7:32 AM MT
Hundreds of thousands of children, many U.S. citizens enrolled in Medicaid, are experiencing acute mental health crises following parental arrests in immigration enforcement operations. Children are presenting with developmental regression, somatic complaints including stomachaches, sleep disturbances, and academic decline. Research indicates these separations produce long-term behavioral health consequences requiring sustained clinical intervention. Medicaid managed care organizations face increased utilization in pediatric behavioral health services, emergency department visits for mental health crises, and demand for trauma-informed care coordination.
Why it matters for managed careMedicaid MCOs covering pediatric populations will see increased behavioral health utilization, higher medical costs from stress-related physical symptoms, and need for expanded trauma-informed care networks as citizen children lose access to parents regardless of the children's own immigration status.
Industry·7:31 AM MT
STAT News published a video episode examining the future trajectory of GLP-1 weight loss medications. The segment, hosted by Alex Hogan, explores upcoming developments in the GLP-1 drug class, which includes medications like Ozempic and Wegovy. The episode appears to focus on market trends and pharmaceutical industry developments related to these medications. No specific policy changes, regulatory actions, or Medicaid coverage decisions are reported.
Why it matters for managed careGLP-1 drugs represent a significant and growing Medicaid pharmacy benefit cost, but this video does not address Medicaid-specific coverage policy, utilization management, or budget impact.